Access cutting-edge kidney cancer treatment through this clinical trial at a research site in La Jolla. Study-provided care at no cost to qualified participants.
Access kidney cancer specialists in La Jolla at no cost
This study follows strict safety protocols and ethical guidelines
All study-related kidney cancer treatment provided free
This phase II trial studies the effects of combination therapy with bevacizumab, erlotinib, and atezolizumab in treating patients with hereditary leiomyomatosis and kidney cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Bevacizumab is in a class of medications called antiangiogenic agents. They work by stopping the formation of blood vessels that bring oxygen and nutrients to tumors. This may slow the growth and spre
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this kidney cancer clinical trial in La Jolla, CA
If you're searching for kidney cancer treatment options in La Jolla, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our La Jolla research site is actively enrolling participants for this clinical trial. You'll receive care from experienced kidney cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.